What are the therapeutic options for BRCA-related cancers?
The treatment of BRCA-related cancers often involves standard cancer therapies, such as surgery, chemotherapy, and radiation. However, there are also targeted therapies specifically for BRCA-mutated cancers, including:
- PARP inhibitors (e.g., olaparib, rucaparib), which exploit the DNA repair weaknesses in cancer cells with BRCA mutations. - Platinum-based chemotherapy, which is particularly effective in BRCA-mutated cancers due to their DNA repair deficiencies.
